{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:43:30Z","timestamp":1774597410923,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1-AI068613"],"award-info":[{"award-number":["UM1-AI068613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1-AI068617"],"award-info":[{"award-number":["UM1-AI068617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1-AI068619"],"award-info":[{"award-number":["UM1-AI068619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223829","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T18:46:52Z","timestamp":1570733212000},"page":"e0223829","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-6878","authenticated-orcid":true,"given":"Philip J.","family":"Palumbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-9000","authenticated-orcid":true,"given":"Jessica M.","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn","family":"Breaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estelle","family":"Piwowar-Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-9263","authenticated-orcid":true,"given":"Erica L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngo T. K.","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7689-4002","authenticated-orcid":true,"given":"Mariya","family":"Liulchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifah","family":"Anandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Viet","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostyantyn","family":"Dumchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubairi","family":"Djoerban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Hanscom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-7827","authenticated-orcid":true,"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4587-791X","authenticated-orcid":true,"given":"Susan H.","family":"Eshleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"pone.0223829.ref001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.aids.0000218543.46963.6d","article-title":"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis","volume":"20","author":"RF Baggaley","year":"2006","journal-title":"AIDS"},{"key":"pone.0223829.ref002","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"L Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"pone.0223829.ref003","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugpo.2007.01.012","article-title":"Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union","volume":"18","author":"D Wolfe","year":"2007","journal-title":"Int J Drug Policy"},{"key":"pone.0223829.ref004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","volume":"376","author":"D Wolfe","year":"2010","journal-title":"Lancet"},{"key":"pone.0223829.ref005","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"S Larney","year":"2017","journal-title":"Lancet Glob Health"},{"key":"pone.0223829.ref006","first-page":"114","article-title":"Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study","volume":"21","author":"S Bassetti","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0223829.ref007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jech.53.1.4","article-title":"Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group","volume":"53","author":"MP Carrieri","year":"1999","journal-title":"J Epidemiol Community Health"},{"key":"pone.0223829.ref008","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.drugpo.2007.05.002","article-title":"Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview","volume":"18","author":"F Lert","year":"2007","journal-title":"Int J Drug Policy"},{"key":"pone.0223829.ref009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugpo.2007.02.010","article-title":"Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002\u20132004","volume":"18","author":"MC Donoghoe","year":"2007","journal-title":"Int J Drug Policy"},{"key":"pone.0223829.ref010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1473-3099(10)70097-9","article-title":"Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis","volume":"10","author":"D Werb","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"pone.0223829.ref011","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00042560-200004150-00006","article-title":"Impact of medical and nonmedical factors on physician decision making for HIV\/AIDS antiretroviral treatment","volume":"23","author":"LM Bogart","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0223829.ref012","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00042560-200104150-00005","article-title":"Provider assessment of adherence to HIV antiretroviral therapy","volume":"26","author":"DR Bangsberg","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0223829.ref013","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.aids.0000176219.48484.f1","article-title":"Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use","volume":"19","author":"E Wood","year":"2005","journal-title":"AIDS"},{"key":"pone.0223829.ref014","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(18)31487-9","article-title":"A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study","volume":"392","author":"WC Miller","year":"2018","journal-title":"Lancet"},{"key":"pone.0223829.ref015","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"BM Mathers","year":"2010","journal-title":"Lancet"},{"key":"pone.0223829.ref016","first-page":"168","volume":"11","author":"J DeHovitz","year":"2014","journal-title":"The HIV epidemic in Eastern Europe and Central Asia. Curr HIV\/AIDS Rep"},{"key":"pone.0223829.ref017","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016"},{"key":"pone.0223829.ref018","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10461-018-2379-8","article-title":"Use of antiretroviral drug testing to assess the accuracy of self-reported data from HIV-infected people who inject drugs","volume":"23","author":"JM Fogel","year":"2019","journal-title":"AIDS Behav"},{"key":"pone.0223829.ref019","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1093\/nar\/gku739","article-title":"COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification","volume":"42","author":"D Struck","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"pone.0223829.ref020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.meegid.2013.04.032","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"AC Pineda-Pena","year":"2013","journal-title":"Infect Genet Evol"},{"key":"pone.0223829.ref021","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1089\/aid.1995.11.1413","article-title":"A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences","volume":"11","author":"AC Siepel","year":"1995","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0223829.ref022","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2014.03.016","article-title":"The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood","volume":"433","author":"MA Marzinke","year":"2014","journal-title":"Clin Chim Acta"},{"key":"pone.0223829.ref023","doi-asserted-by":"crossref","first-page":"e02743","DOI":"10.1128\/AAC.02743-16","article-title":"Evaluation of a multidrug assay for monitoring adherence to a regimen for HIV preexposure prophylaxis in a clinical study, HIV Prevention Trials Network 073","volume":"61","author":"Y Zhang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0223829.ref024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/COH.0000000000000534","article-title":"HIV subtype diversity worldwide","volume":"14","author":"N Bbosa","year":"2019","journal-title":"Curr Opin HIV AIDS"},{"key":"pone.0223829.ref025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7883\/yoken.JJID.2016.512","article-title":"An alarmingly high proportion of HIV-1 isolates carrying mutations corresponding to resistance to antiretroviral drugs among HIV-positive high-risk groups in Central Vietnam: a substudy of the National Sentinel Survey","volume":"70","author":"HT Do","year":"2017","journal-title":"Jpn J Infect Dis"},{"key":"pone.0223829.ref026","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/cid\/cix428","article-title":"Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among human immunodeficiency virus-infected people who use illicit drugs in a Canadian setting","volume":"65","author":"ME Socias","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pone.0223829.ref027","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/QAI.0000000000000196","article-title":"Low prevalence of transmitted drug resistance of HIV-1 during 2008\u20132012 antiretroviral therapy scaling up in Southern Vietnam","volume":"66","author":"J Tanuma","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0223829.ref028","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/jac\/dku473","article-title":"Pretreatment HIV-1 drug resistance to first-line drugs: results from a baseline assessment of a large cohort initiating ART in Vietnam, 2009\u201310","volume":"70","author":"QD Pham","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"pone.0223829.ref029","article-title":"HIV drug resistance prevention, surveillance and monitoring in the Western Pacific region","author":"World Health Organization","year":"2009"},{"key":"pone.0223829.ref030","doi-asserted-by":"crossref","first-page":"e94495","DOI":"10.1371\/journal.pone.0094495","article-title":"Patterns of transmitted HIV drug resistance in Europe vary by risk group","volume":"9","author":"D Frentz","year":"2014","journal-title":"PLoS One"},{"key":"pone.0223829.ref031","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00705-013-1933-y","article-title":"Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade","volume":"159","author":"G Yebra","year":"2014","journal-title":"Arch Virol"},{"key":"pone.0223829.ref032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dku372","article-title":"Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype","volume":"70","author":"M Parczewski","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"pone.0223829.ref033","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/dkn002","article-title":"Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan","volume":"61","author":"SY Chang","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"pone.0223829.ref034","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijid.2008.08.028","article-title":"Primary drug resistance in antiretroviral-naive injection drug users","volume":"13","author":"HK Tossonian","year":"2009","journal-title":"Int J Infect Dis"},{"key":"pone.0223829.ref035","doi-asserted-by":"crossref","first-page":"e0126955","DOI":"10.1371\/journal.pone.0126955","article-title":"Transmitted drug resistance mutations in antiretroviral-naive injection drug users with chronic HIV-1 infection in Iran","volume":"10","author":"A Memarnejadian","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:06:41Z","timestamp":1589000801000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223829"}},"subtitle":[],"editor":[{"given":"Matt A.","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223829","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]}}}